Anatimon en es it fr

Anatimon Brand names, Anatimon Analogs

Anatimon Brand Names Mixture

  • No information avaliable

Anatimon Chemical_Formula

C20H23NS

Anatimon RX_link

No information avaliable

Anatimon fda sheet

Anatimon msds (material safety sheet)

Anatimon Synthesis Reference

No information avaliable

Anatimon Molecular Weight

309.469 g/mol

Anatimon Melting Point

< 25 oC

Anatimon H2O Solubility

Soluble as HCl salt

Anatimon State

Liquid

Anatimon LogP

5.7

Anatimon Dosage Forms

Tablets (oral, 1 mg)

Anatimon Indication

Used for the symptomatic treatment of parkinsonism.

Anatimon Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Anatimon Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Anatimon side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Anatimon Patient Information

Anatimon Organisms Affected

Humans and other mammals